Lv21
120 积分 2023-03-05 加入
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer
3小时前
已完结
Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
3小时前
已完结
A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis A Bidirectional Mendelian Randomization Study
5个月前
已完结
Comprehensive analysis of single-cell transcriptomics and genetic factors reveals the mechanisms and preventive strategies for the progression from pulmonary fibrosis to lung cancer
5个月前
已完结
Linking macrophage metabolism to function in the tumor microenvironment
7个月前
已完结
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and non-small cell lung cancer survival
8个月前
已完结
A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors
8个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
10个月前
已完结
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study
10个月前
已完结
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
1年前
已完结
皖公网安备34019202002308
